Literature DB >> 28194630

Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging.

Enrico Premi1,2, V D Calhoun3,4, V Garibotto5, R Turrone6, A Alberici6, E Cottini6, A Pilotto6, S Gazzina6, M Magoni7, B Paghera8, B Borroni6, A Padovani6.   

Abstract

PURPOSE: [123I]FP-CIT (DaTSCAN®) single-photon emission computed tomography (SPECT) imaging is widely used to study neurodegenerative parkinsonism, by measuring presynaptic dopamine transporter (DAT) in striatal regions. Beyond DAT, [123I]FP-CIT may be considered for other monoaminergic systems, in particular the serotonin transporter (SERT). Independent component analysis (ICA) implemented in source-based morphometry (SBM) could represent an alternative method to explore monoaminergic pathways, studying the relationship among voxels and grouping them into "neurotransmission" networks. PROCEDURES: One hundred forty-three subjects [84 with Parkinson's disease (PD) and 59 control individuals (CG)] underwent DATSCAN® imaging. The [123I]FP-CIT binding was evaluated by multivariate SBM approach, as well as by a whole-brain voxel-wise univariate (statistical parametric mapping, SPM) approach.
RESULTS: As compared to the univariate whole-brain approach (SPM) (only demonstrating striatal [123I]FP-CIT binding reduction in PD group), SBM identified six sources of non-artefactual origin, including basal ganglia and cortical regions as well as brainstem. Among them, three sources (basal ganglia and cortical regions) presented loading scores (as index of [123I]FP-CIT binding) significantly different between PD and CG. Notably, even if not significantly different between PD and CG, the remaining three non-artefactual sources were characterized by a predominant frontal, brainstem, and occipito-temporal involvement.
CONCLUSION: The concept of source blind separation by the application of ICA (as implemented in SBM) represents a feasible approach to be considered in [123I]FP-CIT (DaTSCAN®) SPECT imaging. Taking advantage of this multivariate analysis, specific patterns of variance can be identified (involving either striatal than extrastriatal regions) that could be useful in differentiating neurodegenerative parkinsonisms.

Entities:  

Keywords:  Parkinson’s disease; Source-based morphometry; Statistical parametric mapping; [123I]FP-CIT imaging

Mesh:

Substances:

Year:  2017        PMID: 28194630      PMCID: PMC5783563          DOI: 10.1007/s11307-017-1052-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  51 in total

Review 1.  Modelling with independent components.

Authors:  Christian F Beckmann
Journal:  Neuroimage       Date:  2012-02-18       Impact factor: 6.556

2.  Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.

Authors:  Morten Ziebell; Signe Holm-Hansen; Gerda Thomsen; Aase Wagner; Peter Jensen; Lars H Pinborg; Gitte Moos Knudsen
Journal:  J Nucl Med       Date:  2010-11-15       Impact factor: 10.057

3.  Independent component analysis and clustering improve signal-to-noise ratio for statistical analysis of event-related potentials.

Authors:  Philip M Zeman; Bernie C Till; Nigel J Livingston; James W Tanaka; Peter F Driessen
Journal:  Clin Neurophysiol       Date:  2007-10-29       Impact factor: 3.708

4.  Automated quantification with BRASS reduces equivocal reporting of DaTSCAN (123I-FP-CIT) SPECT studies.

Authors:  Deborah Ruth Pencharz; Paul Hanlon; Riddhika Chakravartty; Shaunak Navalkissoor; Ann-Marie Quigley; Thomas Wagner; Thomas Wagner
Journal:  Nucl Med Rev Cent East Eur       Date:  2014

5.  [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.

Authors:  Mordechai Lorberboym; Therese A Treves; Eldad Melamed; Yair Lampl; Mark Hellmann; Ruth Djaldetti
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

6.  Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.

Authors:  J P Seibyl; K Marek; K Sheff; R M Baldwin; S Zoghbi; Y Zea-Ponce; D S Charney; C H van Dyck; P B Hoffer; R B Innis
Journal:  J Nucl Med       Date:  1997-09       Impact factor: 10.057

7.  The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.

Authors:  Sean J Colloby; John T O'Brien; John D Fenwick; Michael J Firbank; David J Burn; Ian G McKeith; E David Williams
Journal:  Neuroimage       Date:  2004-11       Impact factor: 6.556

8.  Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation.

Authors:  D Frosini; E Unti; F Guidoccio; C Del Gamba; G Puccini; D Volterrani; U Bonuccelli; R Ceravolo
Journal:  J Neural Transm (Vienna)       Date:  2015-01-23       Impact factor: 3.575

9.  Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study.

Authors:  Francesco Roselli; Nicola M Pisciotta; Michele Pennelli; Maria S Aniello; Angelo Gigante; Maria F De Caro; Ermanno Ferrannini; Bruno Tartaglione; Artor Niccoli-Asabella; Giovanni Defazio; Paolo Livrea; Giuseppe Rubini
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

10.  Age-related changes in processing speed: unique contributions of cerebellar and prefrontal cortex.

Authors:  Mark A Eckert; Noam I Keren; Donna R Roberts; Vince D Calhoun; Kelly C Harris
Journal:  Front Hum Neurosci       Date:  2010-03-08       Impact factor: 3.169

View more
  5 in total

1.  Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Authors:  Andrea Pilotto; Francesca Schiano di Cola; Enrico Premi; Roberto Grasso; Rosanna Turrone; Stefano Gipponi; Andrea Scalvini; Elisabetta Cottini; Barbara Paghera; Valentina Garibotto; Maria Cristina Rizzetti; Laura Bonanni; Barbara Borroni; Silvia Morbelli; Flavio Nobili; Ugo Paolo Guerra; Daniela Perani; Alessandro Padovani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-16       Impact factor: 9.236

2.  Data-driven identification of diagnostically useful extrastriatal signal in dopamine transporter SPECT using explainable AI.

Authors:  Mahmood Nazari; Andreas Kluge; Ivayla Apostolova; Susanne Klutmann; Sharok Kimiaei; Michael Schroeder; Ralph Buchert
Journal:  Sci Rep       Date:  2021-11-25       Impact factor: 4.379

3.  Phenotypic and genetic associations between gray matter covariation and tool use skill in chimpanzees (Pan troglodytes): Repeatability in two genetically isolated populations.

Authors:  M M Mulholland; S J Schapiro; C C Sherwood; W D Hopkins
Journal:  Neuroimage       Date:  2022-05-10       Impact factor: 7.400

4.  Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort.

Authors:  Nicolas Nicastro; Valentina Garibotto; Pierre R Burkhard
Journal:  BMC Neurol       Date:  2020-05-16       Impact factor: 2.474

5.  Imaging of dopamine transporters in Parkinson disease: a meta-analysis of 18 F/123 I-FP-CIT studies.

Authors:  Yanyan Kong; Chencheng Zhang; Kawai Liu; Aparna Wagle Shukla; Bomin Sun; Yihui Guan
Journal:  Ann Clin Transl Neurol       Date:  2020-08-14       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.